Predicting the survival of bladder carcinoma patients treated with radical cystectomy

Cancer

Volumn 88, Issue 10, 2000, Pages 2326-2332

  Cheng, Liang ^a   Weaver, Amy L ^b   Leibovich, Bradley C ^b   Ramnani, Dharamdas M ^b   Neumann, Roxann M ^b   Scherer, Beth G ^b   Nehra, Ajay ^b   Zincke, Horst ^b   Bostwick, David G ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BOSTWICK LABORATORIES   (United States)

Author keywords

Bladder neoplasms; Cancer size; Cystectomy; Margin; Metastasis; Progression; Recurrence; Staging; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 0034656998     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2326::AID-CNCR17>3.0.CO;2-T     Document Type: Article

References (39)

1. Droller MJ. Bladder cancer: state-of-the-art care. CA Cancer J Clin 1998;48:269-84.
2. Soloway MS, Lopez AE, Patel J, Lu Y. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer 1994;73:1926-31.
3. Smith JA, Crawford ED, Paradelo JC, Blumenstein B, Herschman B, Grossman HB, et al. Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a Phase III Intergroup Study. J Urol 1997;157:805-8.
4. Holmang S, Hedelin H, Borghede G, Johansson SL. Long-term follow-up of a bladder carcinoma cohort: questionable value of radical radiotherapy. J Urol 1997;157:1642-6.
5. Zietman AL, Shipley WU, Kaufman DS. The combination of cis-platin based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int J Radiat Oncol Biol Phys 1993;27:161-70.
6. Martinez-Pineiro JA, Martin MA, Arocena F, Flores N, Roncero CR, Portillo JA, et al. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J Urol 1995;153:964-73.
7. Thrasher JB, Crawford ED. Current management of invasive and metastatic transitional cell carcinoma of the bladder. J Urol 1993;149:957-72.
8. Prout GRJ. The surgical management of bladder carcinoma. Urol Clin North Am 1976;3:149-75.
9. Skinner DG. Current perspectives in the management of high grade invasive bladder cancer. Cancer 1980;45:1866-74.
10. Montie JE, Straffon RA, Stewart BH. Radical cystectomy without radiation therapy for carcinoma of the bladder. J Urol 1984;131:477-82.
11. Figueroa AJ, Stein JP, Dickinson M, Skiner E, Thangathurai D, Mikhail MS, et al. Radical cystectomy for elderly patients with bladder carcinoma: an updated experience with 404 patients. Cancer 1998;83:141-7.
12. Siref LE, Zincke H. Radical cystectomy for historical and pathological T1, N0, M0 (stage A) transitional cell cancer. Urology 1988;31:309-11.
13. Lerner SP, Skinner E, Skinner DG. Radical cystectomy in regionally advanced bladder cancer. Urol Clin North Am 1992;19:713-23.
14. Ghoneim MA, El-Mekresh MM, El-Baz MA, El-Attar IA, Ashamallah A. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J Urol 1997;158:393-9.
15. Skinner DG. Current state of classification and staging of bladder cancer. Cancer Res 1977;37:2838-42.
16. Herr HW. Staging invasive bladder tumors. J Surg Oncol 1992;51:217-20.
17. Cummings KB, Barone JG, Ward WS. Diagnosis and staging of bladder cancer. Urol Clin North Am 1992;19:455-65.
18. Bostwick DG, Ramnani DM, Cheng L. Diagnosis and grading of bladder cancer and associated lesions. Urol Clin North Am 1999;26:493-507.
19. Pisters LL, Westney L. The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol 1996;14:112-9.
20. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC cancer staging manual. Philadelphia: Lippincott Raven, 1997.
21. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-8.
22. Cheng L, Neumann RM, Scherer BG, Weaver AL, Nehra A, Zincke H, et al. Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion. Cancer 1999;85: 2638-47.
23. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1994;86:829-35.
24. Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Clinical variables which serve as predictors of cancer-specific survival among patients treated by radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994;73:1708-15.
25. Frazier HA, Robertson JE, Dodge RK, Paulson DF. The value of pathologic factors in predicting cancer-specific survival among patients treated by radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993;71:3993-4001.
26. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Preoperative radiotherapy for muscle-invasive carcinoma. Cancer 1994;74:2819-27.
27. Pollack A, Zagars GK, Cole CJ, Dinney CPN, Swanson DA, Grossman HB. The relationship of local control to distant metastasis in muscle invasive bladder cancer. J Urol 1995; 154:2059-64.
28. Fung CF, Shipley WU, Young RH, Griffin PP, Convery KM, Kaufman DS, et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 1991;9:1533-42.
29. Narayana AS, Loening SA, Slymen DJ, Culp DA. Bladder cancer: factors affecting survival. J Urol 1983;130:56-60.
30. International collaboration of trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-Urinary Group, Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group, and Club Urologico Espanol de Tratamiento Oncologico group. Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet 1999; 354:533-40.
31. Dimopoulos MA, Moulopoulos LA. Role of adjuvant chemotherapy in the treatment of invasive carcinoma of the urinary bladder. J Clin Oncol 1998;16:1601-12.
32. Stockle M, Wellek S, Meyenburg W, Voges GE, Fischer U, Gertenbach U, et al. Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement. Urology 1996;48:868-75.
33. Hellsten S, Rintala E, Wahlqvist R, Malmstrom P-U. Nordic prospective trials of radical cystectomy and neoadjuvant chemotherapy. Eur Urol 1998;33 (Suppl 4):35-8.
34. Kurth K, Tunn U, Ay R, Schroder FH, Pavone-Macaluso M, Debruyne F, et al. Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone. J Urol 1997;158:378-84.
35. Wei C-H, Hsieh R-K, Chiou T-J, Chen K-K, Chang LS, Chen P-M. Adjuvant methotrexate, vinblastine, and cisplatin chemotherapy for invasive transitional cell carcinoma: Taiwan experience. J Urol 1996;155:118-21.
36. Malmstrom PU, Rintala E, Wahlqvist R, Hellstrom P, Hellsten S, Hannisdal E. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 1996;155:1903-6.
37. Logothetis C, Swanson D, Amato R, Banks M, Finn L, Ayala A, et al. Optimal delivery of perioperative chemotherapy: preliminary results of a randomized, prospective, comparative trial of preoperative and postoperative chemotherapy for invasive bladder carcinoma. J Urol 1996;155:1241-5.
38. Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome. J Clin Oncol 1998;16:1298-1301.
39. Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 1998;16:3576-83.